Cargando…
miRNA‐130b‐5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression
Liver fibrosis is a progressive disease accompanied by the deposition of extracellular matrix (ECM). Numerous reports have demonstrated that alterations in the expression of microRNAs (miRNAs) are related to liver disease. However, the effect of individual miRNAs on liver fibrosis has not been studi...
Autores principales: | Wang, Hao, Wang, Zeng, Wang, Yirui, Li, Xiangcheng, Yang, Wenjie, Wei, Song, Shi, Chengyu, Qiu, Jiannan, Ni, Ming, Rao, Jianhua, Cheng, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335697/ https://www.ncbi.nlm.nih.gov/pubmed/34272822 http://dx.doi.org/10.1111/jcmm.16766 |
Ejemplares similares
-
miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression
por: Wei, Song, et al.
Publicado: (2019) -
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
por: Qiu, Jiannan, et al.
Publicado: (2022) -
SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells
por: Zhong, Xiaolin, et al.
Publicado: (2020) -
MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression
por: Wang, Qi, et al.
Publicado: (2020) -
The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis
por: Lambrecht, Joeri, et al.
Publicado: (2015)